Back

A method for lung cancer detection and staging from a drop of blood plasma via Raman spectroscopy of well-based samples (ROWS)

Ember, K. J. I.; Dallaire, F.; D'Amours, E.; Bounaas, M.; Zamani, E.; Le Roy-Pepin, R.; Ksantini, N.; Sheehy, G.; Daoust, F.; Selb, J.; Liberman, M.; Trudel, D.; Leblond, F.

2025-12-18 oncology
10.64898/2025.12.17.25341841 medRxiv
Show abstract

We present a new method for lung pathology detection in blood plasma, including lung cancer staging. Raman spectroscopy uses inelastically scattered laser light to obtain molecular information in a reagent-free manner. Obtaining Raman spectral data from liquid samples has long proven challenging, but we have developed a novel tool for obtaining spectra from 60 l liquid samples within two minutes: Raman of Well-based Samples (ROWS). With a low-cost ROWS device, we analyzed 372 blood plasma samples from a national biobank, including controls (n=92), patients with stage I-II lung cancer (n=99), stage III-IV cancer (n=46), benign tumours (n=36) and other lung conditions (n=99). Machine learning models were built to assess lung cancer stage and lung pathology presence. ROWS achieves up to 94% sensitivity, 90% specificity and 93% accuracy depending on classification. ROWS proves a robust method for rapid, low-cost, user-friendly, point-of-care lung pathology analysis in small quantities of blood plasma. One Sentence SummaryA new way of detecting lung cancer in small volumes of liquid blood plasma was developed using laser-based Raman spectroscopy and metallic wells.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.